START Midwest — Grand Rapids, Michigan

START Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

START Midwest has participated in 122 clinical trials with 66 currently active.

Therapeutic areas: Gastrointestinal Tumors, Colorectal Adenocarcinomas, Gastric Adenocarcinomas.

Sponsors: Pfizer, Symphogen A/S, Sapience Therapeutics.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Midwest?

START Midwest has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Midwest conducted?

START Midwest has 122 clinical trials on record, with 66 currently active. Their work covers Gastrointestinal Tumors, Colorectal Adenocarcinomas, Gastric Adenocarcinomas.

Is START Midwest accredited by Crixeo Health?

START Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.